Neuromeka Finalizes Rights Offering Price at 24,450 KRW, Diluting Existing Shareholders by 25.76%

Neuromeka has finalized the issuance price for its rights offering at 24,450 KRW per share, representing a discount of approximately 16.4% from the current market price of 29,250 KRW.
A total of 3,196,465 new shares will be issued, resulting in a 25.76% dilution of existing shareholders' equity relative to the current 12,409,151 shares outstanding. The combination of high discount and massive dilution poses a significant negative impact on shareholder value.
The specific use of proceeds from the rights offering is not disclosed in this filing, typically such funds are allocated to working capital or debt repayment.
[AI Summary]The finalization of Neuromeka's rights offering results in a severe 25.76% dilution with a 16.4% discount, likely pressuring the stock price in the short term. The lack of clarity on fund usage adds to investment risk.